Watson Syndrome disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Sources

Aliases & Classifications for Watson Syndrome

MalaCards integrated aliases for Watson Syndrome:

Name: Watson Syndrome ⁵⁷ ⁷⁵ ⁷³ ¹² ⁵³

Pulmonic Stenosis with Cafe-Au-Lait Spots ⁵⁷ ⁵

Wtsn ⁵⁷ ⁷³

Cafe-Au-Lait Macules with Pulmonary Stenosis ⁷¹

Pulmonary Stenosis with Cafe-Au-Lait Spots ⁷³

Cafe-Au-Lait Spots with Pulmonic Stenosis ⁵⁷

Characteristics:

Inheritance:

Autosomal dominant ⁵⁷

OMIM®:

⁵⁷ (Updated 08-Dec-2022)

Miscellaneous:
allelic to neurofibromatosis-1 (nf1, )

Classifications:

MalaCards categories:
Global: Genetic diseases
Anatomical: Neuronal diseases Respiratory diseases

See all MalaCards categories (disease lists)

External Ids:

OMIM® ⁵⁷ 193520

MeSH ⁴³ D009456

MedGen ⁴⁰ C0553586

SNOMED-CT via HPO ⁶⁹ 19133005 194021007 205101001 more

UMLS ⁷¹ C0553586

Sources

Summaries for Watson Syndrome

OMIM®: ⁵⁷ Watson syndrome is an autosomal dominant disorder characterized by pulmonic stenosis, cafe-au-lait spots, decreased intellectual ability (Watson, 1967), and short stature (Partington et al., 1985). Most affected individuals have relative macrocephaly and Lisch nodules and about one-third of those affected have neurofibroma (Allanson et al., 1991). (193520) (Updated 08-Dec-2022)

MalaCards based summary: Watson Syndrome, also known as pulmonic stenosis with cafe-au-lait spots, is related to alagille syndrome 1 and alagille syndrome 2. An important gene associated with Watson Syndrome is NF1 (Neurofibromin 1). Affiliated tissues include breast, and related phenotypes are hypertelorism and pectus carinatum

UniProtKB/Swiss-Prot: ⁷³ A syndrome characterized by the presence of pulmonary stenosis, cafe- au-lait spots, and intellectual disability. It is considered as an atypical form of neurofibromatosis.

Wikipedia: ⁷⁵ Watson syndrome is an autosomal dominant condition characterized by Lisch nodules of the ocular iris,... more...

Sources

Related Diseases for Watson Syndrome

Diseases related to Watson Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 14)

#	Related Disease	Score
1	alagille syndrome 1	11.6
2	alagille syndrome 2	11.3
3	neurofibromatosis-noonan syndrome	11.2
4	pulmonary valve stenosis	10.2
5	neurofibromatosis, type i	10.2
6	neurofibromatosis	10.2
7	neurofibroma	10.0
8	cafe-au-lait spots, multiple	9.9
9	noonan syndrome 1	9.9
10	pulmonic stenosis	9.9
11	hyperlipoproteinemia, type iii	9.9
12	lipoprotein quantitative trait locus	9.9
13	liver cirrhosis	9.9
14	plexiform neurofibroma	9.9

Graphical network of the top 20 diseases related to Watson Syndrome:

Sources

Symptoms & Phenotypes for Watson Syndrome

Human phenotypes related to Watson Syndrome:

³⁰ (show all 13)

#	Description	HPO Frequency	HPO Source Accession
1	hypertelorism ³⁰	Very rare (1%)	HP:0000316
2	pectus carinatum ³⁰	Very rare (1%)	HP:0000768
3	low-set ears ³⁰	Very rare (1%)	HP:0000369
4	epicanthus ³⁰	Very rare (1%)	HP:0000286
5	multiple cafe-au-lait spots ³⁰	Very rare (1%)	HP:0007565
6	pulmonic stenosis ³⁰	Very rare (1%)	HP:0001642
7	moderate global developmental delay ³⁰	Very rare (1%)	HP:0011343
8	posteriorly rotated ears ³⁰	Very rare (1%)	HP:0000358
9	axillary freckling ³⁰	Very rare (1%)	HP:0000997
10	inguinal freckling ³⁰	Very rare (1%)	HP:0030052
11	short stature ³⁰		HP:0004322
12	neurofibromas ³⁰		HP:0001067
13	relative macrocephaly ³⁰		HP:0004482

Symptoms via clinical synopsis from OMIM®:

⁵⁷ (Updated 08-Dec-2022)

Growth Height:
short stature

Head And Neck Eyes:
lisch nodules

Cardiovascular Heart:
pulmonary valvular stenosis

Skin Nails Hair Skin:
multiple cafe-au-lait spots
neurofibromas
axillary freckling

Head And Neck Head:
relative macrocephaly

Neurologic Central Nervous System:
low iq

Clinical features from OMIM®:

193520 (Updated 08-Dec-2022)

Sources

Drugs & Therapeutics for Watson Syndrome

Search Clinical Trials, NIH Clinical Center for Watson Syndrome

Sources

Genetic Tests for Watson Syndrome

Sources

Anatomical Context for Watson Syndrome

Organs/tissues related to Watson Syndrome:

MalaCards : Breast

Sources

Publications for Watson Syndrome

Articles related to Watson Syndrome:

(show all 43)

#	Title	Authors	PMID	Year
1	Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome. ⁶² ⁵⁷ ⁵	Tassabehji M...Thakker N	8317503	1993
2	Analysis of mutations at the neurofibromatosis 1 (NF1) locus. ⁵⁷ ⁵	Upadhyaya M...Harper PS	1302608	1992
3	Watson syndrome: is it a subtype of type 1 neurofibromatosis? ⁵³ ⁶² ⁵⁷	Allanson JE...Harper PS	1770531	1991
4	Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation. ⁶² ⁵	Ben-Shachar S...Huson SM	23047742	2013
5	Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation. ⁵	Frayling IM...Upadhyaya M	30530636	2019
6	Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer. ⁵	Yu J...Sung JJ	24951259	2015
7	Fifty-four novel mutations in the NF1 gene and integrated analyses of the mutations that modulate splicing. ⁵	Xu W...Li S	24789688	2014
8	Thirty-nine novel neurofibromatosis 1 (NF1) gene mutations identified in Slovak patients. ⁵	Nemethova M...Zatkova A	23758643	2013
9	Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene. ⁵	Thomas L...Upadhyaya M	22807134	2012
10	An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. ⁵	Upadhyaya M...Messiaen L	17160901	2007
11	Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype. ⁵	Stevenson DA...Carey JC	16542390	2006
12	The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1. ⁵	Jeong SY...Kim HJ	16479075	2006
13	Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain. ⁵	Mattocks C...Whittaker J	15060124	2004
14	Evaluation of genotype-phenotype correlations in neurofibromatosis type 1. ⁵	Castle B...Upadhyaya M	14569132	2003
15	Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. ⁵	Fahsold R...Nurnberg P	10712197	2000
16	Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. ⁵	Klose A...Nurnberg P	9668168	1998
17	The importance of two conserved arginine residues for catalysis by the ras GTPase-activating protein, neurofibromin. ⁵	Sermon BA...Eccleston JF	9545275	1998
18	Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. ⁵	Ahmadian MR...Wittinghofer A	9302992	1997
19	Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. ⁵	DeClue JE...Lowy DR	1568246	1992
20	Absence of linkage of Noonan syndrome to the neurofibromatosis type 1 locus. ⁵⁷	Sharland M...Jeffery S	1348095	1992
21	Phosphorylation of Biologically active analogs of riboflavin. ⁵	Dombrowski JJ...Lamboody JP	190611	1977
22	Pulmonary stenosis, café-au-lait spots, and dull intelligence. ⁵⁷	Watson GH	6025371	1967
23	A rare case of Watson syndrome. ⁶²	Sabzi F...Asadmobini A	36045473	2022
24	Enabling Real-Time Quality-of-Service and Fine-Grained Aggregation for Wireless TSN. ⁶²	Zhang L...Vucetic B	35632308	2022
25	Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma. ⁶²	Liu J...Brutkiewicz RR	29354122	2017
26	Generation of KCL024 research grade human embryonic stem cell line carrying a mutation in NF1 gene. ⁶²	Hewitson H...Ilic D	27345975	2016
27	Generation of KCL025 research grade human embryonic stem cell line carrying a mutation in NF1 gene. ⁶²	Hewitson H...Ilic D	27345978	2016
28	Prediction of disease-related genes based on weighted tissue-specific networks by using DNA methylation. ⁶²	Li M...Wu FX	25350763	2014
29	[Congenital bile duct hypoplasia (Alagille-Watson syndrome)--a rare cause of biliary cirrhosis in adults]. ⁶²	Burnevich EZ...Odintsov AV	23789457	2013
30	A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene. ⁶²	Huffmeier U...Rauch A	17103458	2006
31	Pulmonary artery aneurysm and coronary artery disease in the clinical presentation of watson syndrome. ⁶²	Foster JL...Ikonomidis JS	16863806	2006
32	Molecular and cytogenetic characterisation of a small interstitial de novo 20p13-->p12.3 deletion in a patient with severe growth deficit. ⁶²	Lepretre F...Vasseur F	11856871	2001
33	Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. ⁶²	Lin AE...Friedman JM	11078559	2000
34	The different forms of neurofibromatosis. ⁶²	Ruggieri M	10461778	1999
35	[Plexiform neurofibroma and basal ganglia anomaly in Watson syndrome]. ⁶²	Weber P...Kurlemann G	10412128	1999
36	The neurofibromatoses. An overview. ⁶²	Ruggieri M...Huson SM	10933430	1999
37	Arteriohepatic dysplasia (Alagille syndrome; Watson-Alagille syndrome). ⁶²	MacMillan JC...Heritage M	9890073	1998
38	Alagille syndrome. ⁶²	Krantz ID...Spinner NB	9039994	1997
39	Noonan syndrome with café-au-lait spots and multiple lentigines syndrome are not linked to the neurofibromatosis type 1 locus. ⁶²	Ahlbom BE...Anneren G	7586657	1995
40	Evidence of central nervous system involvement in Watson syndrome. ⁶²	Leao M...da Silva ML	7619195	1995
41	Ursodesoxycholic acid: effect on xanthomas in Alagille-Watson syndrome. ⁶²	Krawinkel MB...Oldigs HD	7877009	1994
42	46,XX/46,XX,del(20)(pter-->p12.2) mosaicism limited to fibroblasts associated with MCA/MR and severe growth deficit. ⁶²	Fryns JP...van den Berghe H	1296522	1992
43	[On the Watson syndrome in the preclimacteric and climacteric age]. ⁶²	SASSI D	13986665	1962

Sources

Genes for Watson Syndrome

Genes related to Watson Syndrome (1 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubMed IDs
1	NF1	Neurofibromin 1	Protein Coding	960.92	Molecular basis known ⁵⁷ Pathogenic ⁵ Likely pathogenic ⁵ Novoseek inferred ⁵³ GeneCards inferred via : Disorders Publications Summaries (show sections)	190611 1302608 1568246 (more) 8317503 9302992 9545275 9668168 10712197 14569132 15060124 16479075 16542390 17160901 22807134 23047742 23758643 24789688 24951259 30530636 1770531

Sources

Variations for Watson Syndrome

ClinVar genetic disease variations for Watson Syndrome:

⁵ (show top 50) (show all 218)

#	Gene	Name	Type	Significance	ClinVarId	dbSNP ID	Position
1	NF1	NM_001042492.3(NF1):c.1882del (p.Tyr628fs)	DEL	Pathogenic	1213688		GRCh37: 17:29552144-29552144 GRCh38: 17:31225126-31225126
2	NF1	NM_001042492.3(NF1):c.888+2T>G	SNV	Pathogenic	951075	rs2066160116	GRCh37: 17:29509685-29509685 GRCh38: 17:31182667-31182667
3	NF1	NM_001042492.3(NF1):c.6897del (p.Lys2300fs)	DEL	Pathogenic	1527847		GRCh37: 17:29665798-29665798 GRCh38: 17:31338780-31338780
4	NF1	NF1, 80-KB DEL	DEL	Pathogenic	342		GRCh37: GRCh38:
5	NF1	NM_001042492.3(NF1):c.2266C>T (p.Gln756Ter)	SNV	Pathogenic	576444	rs1567847905	GRCh37: 17:29554250-29554250 GRCh38: 17:31227232-31227232
6	NF1	NM_001042492.3(NF1):c.3870+1G>T	SNV	Pathogenic	565498	rs1131691075	GRCh37: 17:29562791-29562791 GRCh38: 17:31235773-31235773
7	NF1	NM_001042492.3(NF1):c.4543C>T (p.Gln1515Ter)	SNV	Pathogenic	570950	rs1567862991	GRCh37: 17:29587499-29587499 GRCh38: 17:31260481-31260481
8	NF1	NM_001042492.3(NF1):c.5782G>T (p.Glu1928Ter)	SNV	Pathogenic	187652	rs786203896	GRCh37: 17:29657486-29657486 GRCh38: 17:31330468-31330468
9	NF1	NM_001042492.3(NF1):c.6970C>T (p.Gln2324Ter)	SNV	Pathogenic	428948	rs1131691073	GRCh37: 17:29667571-29667571 GRCh38: 17:31340553-31340553
10	NF1	NM_001042492.3(NF1):c.60+18227_60+18228insGGGCATGAACAACAGAAACTACCTGCTGCCACCTTGGCTTTA	INSERT	Pathogenic	341		GRCh37: 17:29440614-29440615 GRCh38: 17:31113596-31113597
11	NF1	NM_001042492.3(NF1):c.7909C>T (p.Arg2637Ter)	SNV	Pathogenic	184261	rs786201367	GRCh37: 17:29684326-29684326 GRCh38: 17:31357308-31357308
12	NF1	NM_001042492.3(NF1):c.1318C>T (p.Arg440Ter)	SNV	Pathogenic	230673	rs778405030	GRCh37: 17:29533315-29533315 GRCh38: 17:31206297-31206297
13	NF1	NM_001042492.3(NF1):c.5609G>A (p.Arg1870Gln)	SNV	Pathogenic	185354	rs786202112	GRCh37: 17:29654857-29654857 GRCh38: 17:31327839-31327839
14	NF1	NM_001042492.3(NF1):c.5902C>T (p.Arg1968Ter)	SNV	Pathogenic	343	rs137854552	GRCh37: 17:29661945-29661945 GRCh38: 17:31334927-31334927
15	NF1	NM_001042492.3(NF1):c.2970_2972del (p.Met992del)	DEL	Pathogenic	363	rs267606606	GRCh37: 17:29556972-29556974 GRCh38: 17:31229954-31229956
16	NF1	NM_001042492.3(NF1):c.5489G>T (p.Arg1830Leu)	SNV	Pathogenic	208854	rs771529172	GRCh37: 17:29654737-29654737 GRCh38: 17:31327719-31327719
17	NF1	NM_001042492.3(NF1):c.6006+1G>A	SNV	Pathogenic	488817	rs1555534433	GRCh37: 17:29662050-29662050 GRCh38: 17:31335032-31335032
18	NF1	NM_001042492.3(NF1):c.6855C>A (p.Tyr2285Ter)	SNV	Pathogenic	185082	rs772295894	GRCh37: 17:29665757-29665757 GRCh38: 17:31338739-31338739
19	NF1	NM_001042492.3(NF1):c.3827G>A (p.Arg1276Gln)	SNV	Pathogenic Pathogenic	68341	rs137854556	GRCh37: 17:29562747-29562747 GRCh38: 17:31235729-31235729
20	NF1	NM_001042492.3(NF1):c.5488C>T (p.Arg1830Cys)	SNV	Pathogenic	208853	rs797045139	GRCh37: 17:29654736-29654736 GRCh38: 17:31327718-31327718
21	NF1	NM_001042492.3(NF1):c.2446C>T (p.Arg816Ter)	SNV	Pathogenic	280055	rs886041347	GRCh37: 17:29556079-29556079 GRCh38: 17:31229061-31229061
22	NF1	NM_001042492.3(NF1):c.2540T>C (p.Leu847Pro)	SNV	Pathogenic	68323	rs199474747	GRCh37: 17:29556173-29556173 GRCh38: 17:31229155-31229155
23	NF1	NM_001042492.3(NF1):c.3445A>G (p.Met1149Val)	SNV	Pathogenic	527517	rs1187097568	GRCh37: 17:29559848-29559848 GRCh38: 17:31232830-31232830
24	NF1	NM_001042492.3(NF1):c.5311A>G (p.Lys1771Glu)	SNV	Pathogenic	428982	rs1131691103	GRCh37: 17:29654559-29654559 GRCh38: 17:31327541-31327541
25	NF1	NM_001042492.3(NF1):c.4330A>G (p.Lys1444Glu)	SNV	Pathogenic	336	rs137854550	GRCh37: 17:29585518-29585518 GRCh38: 17:31258500-31258500
26	NF1	NM_001042492.3(NF1):c.5991G>A (p.Trp1997Ter)	SNV	Pathogenic	233869	rs876660696	GRCh37: 17:29662034-29662034 GRCh38: 17:31335016-31335016
27	NF1	NM_001042492.3(NF1):c.3447G>T (p.Met1149Ile)	SNV	Likely Pathogenic	457650	rs1064794277	GRCh37: 17:29559850-29559850 GRCh38: 17:31232832-31232832
28	NF1	NM_001042492.3(NF1):c.1392+5G>T	SNV	Uncertain Significance	480071	rs199999754	GRCh37: 17:29533394-29533394 GRCh38: 17:31206376-31206376
29	NF1	NM_001042492.3(NF1):c.1987G>A (p.Gly663Arg)	SNV	Uncertain Significance	184278	rs140653372	GRCh37: 17:29552254-29552254 GRCh38: 17:31225236-31225236
30	NF1	NM_001042492.3(NF1):c.5513C>G (p.Ser1838Cys)	SNV	Uncertain Significance Uncertain Significance	142804	rs368654378	GRCh37: 17:29654761-29654761 GRCh38: 17:31327743-31327743
31	LOC111811965, NF1	NM_000267.3(NF1):c.-363T>C	SNV	Uncertain Significance	890653	rs1911498673	GRCh37: 17:29421965-29421965 GRCh38: 17:31094947-31094947
32	NF1	NM_001042492.3(NF1):c.731-6A>C	SNV	Uncertain Significance	215725	rs369366499	GRCh37: 17:29509520-29509520 GRCh38: 17:31182502-31182502
33	NF1	NM_001042492.3(NF1):c.2023G>A (p.Gly675Arg)	SNV	Uncertain Significance	230614	rs779546178	GRCh37: 17:29553474-29553474 GRCh38: 17:31226456-31226456
34	NF1	NM_001042492.3(NF1):c.3436G>A (p.Val1146Ile)	SNV	Uncertain Significance	141451	rs201047812	GRCh37: 17:29559839-29559839 GRCh38: 17:31232821-31232821
35	NF1	NM_001042492.3(NF1):c.4207G>A (p.Gly1403Ser)	SNV	Uncertain Significance	141711	rs138227618	GRCh37: 17:29585395-29585395 GRCh38: 17:31258377-31258377
36	NF1	NM_001042492.3(NF1):c.5049C>T (p.Asn1683=)	SNV	Uncertain Significance	184710	rs140994965	GRCh37: 17:29653051-29653051 GRCh38: 17:31326033-31326033
37	NF1	NM_001042492.3(NF1):c.5160G>T (p.Glu1720Asp)	SNV	Uncertain Significance	231040	rs773378630	GRCh37: 17:29653162-29653162 GRCh38: 17:31326144-31326144
38	NF1	NM_001042492.3(NF1):c.7110C>T (p.His2370=)	SNV	Uncertain Significance	413033	rs201881479	GRCh37: 17:29670074-29670074 GRCh38: 17:31343056-31343056
39	NF1	NM_001042492.3(NF1):c.2378A>C (p.Asn793Thr)	SNV	Uncertain Significance	484027	rs772543826	GRCh37: 17:29554593-29554593 GRCh38: 17:31227575-31227575
40	NF1	NM_001042492.3(NF1):c.8105A>T (p.Tyr2702Phe)	SNV	Uncertain Significance	41679	rs201824349	GRCh37: 17:29685632-29685632 GRCh38: 17:31358614-31358614
41	NF1	NM_001042492.3(NF1):c.3867C>T (p.Phe1289=)	SNV	Uncertain Significance	184320	rs138186428	GRCh37: 17:29562787-29562787 GRCh38: 17:31235769-31235769
42	NF1	NM_001042492.3(NF1):c.7323T>G (p.Ala2441=)	SNV	Uncertain Significance	413024	rs765750009	GRCh37: 17:29677202-29677202 GRCh38: 17:31350184-31350184
43	NF1	NM_001042492.3(NF1):c.8041A>G (p.Ile2681Val)	SNV	Uncertain Significance	141895	rs146315101	GRCh37: 17:29685568-29685568 GRCh38: 17:31358550-31358550
44	NF1	NM_001042492.3(NF1):c.1866T>C (p.Cys622=)	SNV	Uncertain Significance	237524	rs753245823	GRCh37: 17:29552133-29552133 GRCh38: 17:31225115-31225115
45	NF1	NM_001042492.3(NF1):c.7520C>T (p.Thr2507Ile)	SNV	Uncertain Significance	141844	rs149055633	GRCh37: 17:29679337-29679337 GRCh38: 17:31352319-31352319
46	NF1	NM_001042492.3(NF1):c.7396A>G (p.Ile2466Val)	SNV	Uncertain Significance	216411	rs748027595	GRCh37: 17:29677275-29677275 GRCh38: 17:31350257-31350257
47	NF1	NM_001042492.3(NF1):c.7354C>T (p.Arg2452Cys)	SNV	Uncertain Significance	220184	rs377662483	GRCh37: 17:29677233-29677233 GRCh38: 17:31350215-31350215
48	NF1	NM_001042492.3(NF1):c.5729C>G (p.Ser1910Cys)	SNV	Uncertain Significance	484003	rs751904277	GRCh37: 17:29657433-29657433 GRCh38: 17:31330415-31330415
49	NF1	NM_001042492.3(NF1):c.4201A>T (p.Ser1401Cys)	SNV	Uncertain Significance	404507	rs1060500310	GRCh37: 17:29585389-29585389 GRCh38: 17:31258371-31258371
50	NF1	NM_001042492.3(NF1):c.3811A>G (p.Met1271Val)	SNV	Uncertain Significance	457669	rs746583007	GRCh37: 17:29562731-29562731 GRCh38: 17:31235713-31235713

Sources

Expression for Watson Syndrome

Search GEO for disease gene expression data for Watson Syndrome.

Sources

Pathways for Watson Syndrome

Sources

GO Terms for Watson Syndrome

Sources

Sources for Watson Syndrome

¹ BitterDB

² CDC

³ Cell Signaling Technology

⁴ ClinicalTrials

⁵ ClinVar

⁶ CNVD

⁷ Cochrane Library

⁸ Cosmic

⁹ dbSNP

¹⁰ DGIdb

¹¹ Disease Ontology

¹² diseasecard

¹³ DiseaseEnhancer

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ EFO

¹⁷ ExPASy

¹⁸ FMA

¹⁹ GARD

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HMDB

³⁰ HPO

³¹ ICD10

³² ICD10 via Orphanet

³³ ICD11

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ LifeMap

³⁷ LncRNADisease

³⁸ LOVD

³⁹ MalaCards

⁴⁰ MedGen

⁴¹ MedlinePlus

⁴² MedlinePlus Genetics

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NINDS

⁵³ Novoseek

⁵⁴ Novus Biologicals

⁵⁵ ODiseA

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 08-Dec-2022)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubChem

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ WikiPathways

⁷⁵ Wikipedia

WTSN MCID: WTS001 MIFTS: 30	Watson Syndrome (WTSN) Categories: Genetic diseases, Neuronal diseases, Respiratory diseases	Data Licensing For inquiries, contact: [email protected]
Genes Variations Tissues Related diseases Publications Symptoms & Phenotypes Expand all tables

Watson Syndrome (WTSN)

Aliases & Classifications for Watson Syndrome

MalaCards integrated aliases for Watson Syndrome:

Characteristics:

Inheritance:

OMIM®:

Classifications:

External Ids:

Summaries for Watson Syndrome

Related Diseases for Watson Syndrome

Diseases related to Watson Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Watson Syndrome:

Symptoms & Phenotypes for Watson Syndrome

Human phenotypes related to Watson Syndrome:

Symptoms via clinical synopsis from OMIM®:

Clinical features from OMIM®:

Drugs & Therapeutics for Watson Syndrome

Genetic Tests for Watson Syndrome

Anatomical Context for Watson Syndrome

Organs/tissues related to Watson Syndrome:

Publications for Watson Syndrome

Articles related to Watson Syndrome:

Genes for Watson Syndrome

Genes related to Watson Syndrome (1 elite genes):

Variations for Watson Syndrome

ClinVar genetic disease variations for Watson Syndrome:

Expression for Watson Syndrome

Pathways for Watson Syndrome

GO Terms for Watson Syndrome

Sources for Watson Syndrome